510(k) K232017
K232017 is an FDA 510(k) premarket notification submitted by Ark Diagnostics, Inc. for the device "ARK Methotrexate II Assay". The FDA issued a decision of Substantially Equivalent on Dec 20, 2023. The device falls under product code LAO (Enzyme Immunoassay, Methotrexate), a Class U device. Ark Diagnostics, Inc. has 16 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 20, 2023
- Date Received
- Jul 7, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Methotrexate
- Device Class
- Class U
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Ark Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.